المؤلفون: Logue JM; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.; Department of Internal Medicine, University of South Florida, Tampa, FL, USA., Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA. Julio.C.Chavez@moffitt.org.

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2021 Oct 26; Vol. 22 (12), pp. 112. Date of Electronic Publication: 2021 Oct 26.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive* , Radiotherapy* , Stem Cell Transplantation*, Antineoplastic Agents/*therapeutic use , Immune Checkpoint Inhibitors/*therapeutic use , Lymphoma, Large B-Cell, Diffuse/*therapy , Neoplasm Recurrence, Local/*therapy, Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Benzodiazepines/therapeutic use ; Consolidation Chemotherapy ; Humans ; Hydrazines/therapeutic use ; Immunoconjugates/therapeutic use ; Receptors, Chimeric Antigen ; Treatment Failure ; Triazoles/therapeutic use

المؤلفون: Kim P; Yale Brain Tumor Center, Yale Cancer Center and Department of Neurology, LLCI 920, Yale School of Medicine, 15 York Street, New Haven, CT, 06510, USA., Omuro A; Yale Brain Tumor Center, Yale Cancer Center and Department of Neurology, LLCI 920, Yale School of Medicine, 15 York Street, New Haven, CT, 06510, USA. antonio.omuro@yale.edu.

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2020 Jul 28; Vol. 21 (9), pp. 74. Date of Electronic Publication: 2020 Jul 28.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Central Nervous System Neoplasms/*therapy , Lymphoma/*therapy, Central Nervous System Neoplasms/diagnosis ; Central Nervous System Neoplasms/etiology ; Central Nervous System Neoplasms/mortality ; Clinical Decision-Making ; Combined Modality Therapy/adverse effects ; Combined Modality Therapy/methods ; Consolidation Chemotherapy ; Disease Management ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Lymphoma/diagnosis ; Lymphoma/etiology ; Lymphoma/mortality ; Prognosis ; Radiotherapy ; Treatment Outcome

المؤلفون: Daneshbod Y; Shiraz Molecular Pathology Research Center, Shiraz, Iran.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kohan L; Shiraz Molecular Pathology Research Center, Shiraz, Iran.; Department of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, Iran., Taghadosi V; Shiraz Molecular Pathology Research Center, Shiraz, Iran., Weinberg OK; Department of Pathology, Boston Children's Hospital, 300 Longwood Ave Bader 135, Boston, MA, 02115, USA. Olga.weinberg@childrens.harvard.edu., Arber DA; Department of Pathology, University of Chicago, Chicago, IL, USA.

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2019 Feb 11; Vol. 20 (2), pp. 15. Date of Electronic Publication: 2019 Feb 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Chromosome Aberrations*, Leukemia, Myeloid, Acute/*diagnostic imaging , Leukemia, Myeloid, Acute/*therapy, Antineoplastic Agents/therapeutic use ; Consolidation Chemotherapy ; Hematopoietic Stem Cell Transplantation ; Humans ; Karyotype ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/pathology ; Prognosis ; Remission Induction ; Tumor Suppressor Protein p53/genetics

المؤلفون: Bhudia, Jyotsna, Glynne-Jones, Robert^{Aff2, IDs11864022009615_cor2}

المصدر: Current Treatment Options in Oncology. 23(4):453-473

المؤلفون: Nazeef M; Department of Medicine, Division of Hematology/Oncology, University of Wisconsin School of Medicine and Public Health, 1111 Highland Ave. 4059 WIMR, Madison, WI, 53705, USA., Kahl BS

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2015 Jun; Vol. 16 (6), pp. 29.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Lymphoma, Mantle-Cell/*drug therapy, Consolidation Chemotherapy ; Humans ; Induction Chemotherapy ; Lymphoma, Mantle-Cell/diagnosis ; Lymphoma, Mantle-Cell/etiology ; Lymphoma, Mantle-Cell/mortality ; Lymphoma, Mantle-Cell/therapy ; Maintenance Chemotherapy ; Prognosis ; Stem Cell Transplantation ; Treatment Outcome ; Watchful Waiting

المؤلفون: Motyckova G; Dana-Farber Cancer Institute, Boston, MA 02215, USA. gmotyckova@partners.org, Stone RM

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2011 Dec; Vol. 12 (4), pp. 341-53.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute/*therapy, Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Chromosome Aberrations ; Consolidation Chemotherapy ; Hematopoietic Stem Cell Transplantation ; Humans ; Induction Chemotherapy ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/mortality ; Prognosis ; Treatment Outcome

المؤلفون: Peter B Kim, Antonio Omuro

المصدر: Current Treatment Options in Oncology. 21

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Lymphoma, medicine.medical_treatment, Clinical Decision-Making, ThioTEPA, Procarbazine, Central Nervous System Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, Pharmacology (medical), Chemotherapy, Radiotherapy, Performance status, business.industry, Hematopoietic Stem Cell Transplantation, Primary central nervous system lymphoma, Disease Management, Prognosis, medicine.disease, Combined Modality Therapy, Consolidation Chemotherapy, Radiation therapy, Regimen, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Rituximab, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9791184fb65f03b2ee055617a3ea3fad
https://doi.org/10.1007/s11864-020-00758-4

المؤلفون: Olga K. Weinberg, Daniel A. Arber, Vahideh Taghadosi, Yahya Daneshbod, Leila Kohan

المصدر: Current Treatment Options in Oncology. 20

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Daunorubicin, Karyotype, Azacitidine, Decitabine, Antineoplastic Agents, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Idarubicin, Pharmacology (medical), neoplasms, Chromosome Aberrations, Venetoclax, business.industry, Remission Induction, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, Prognosis, Consolidation Chemotherapy, Transplantation, Leukemia, Myeloid, Acute, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Cytarabine, Tumor Suppressor Protein p53, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::900f507a4b8dc997f2c0fd1ae56456f6
https://doi.org/10.1007/s11864-019-0612-y

المؤلفون: Shadia I. Jalal, Hirva Mamdani, Nasser H. Hanna

المصدر: Current treatment options in oncology. 16(10)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Lung Neoplasms, Paclitaxel, medicine.medical_treatment, Antineoplastic Agents, Carboplatin, chemistry.chemical_compound, Risk Factors, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), Precision Medicine, Lung cancer, Etoposide, Cisplatin, Chemotherapy, Performance status, business.industry, Patient Selection, Consolidation Chemotherapy, medicine.disease, Radiation therapy, chemistry, Chemotherapy, Adjuvant, Radiotherapy, Adjuvant, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efeb930f85ae99dddfe005763658306e
https://pubmed.ncbi.nlm.nih.gov/26233240

المؤلفون: Gabriela Motyckova, Richard Stone

المصدر: Current Treatment Options in Oncology. 12:341-353

مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Population, Internal medicine, Biomarkers, Tumor, medicine, Humans, Clofarabine, Pharmacology (medical), Intensive care medicine, education, Aged, Aged, 80 and over, Chromosome Aberrations, Chemotherapy, education.field_of_study, business.industry, Hematopoietic Stem Cell Transplantation, Induction chemotherapy, Consolidation Chemotherapy, Induction Chemotherapy, Prognosis, medicine.disease, Transplantation, Leukemia, Myeloid, Acute, Leukemia, Treatment Outcome, Cytarabine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3aba64624dbc7bc092637b150eaa7d5
https://doi.org/10.1007/s11864-011-0162-4